9Yu SY, Sun Y, Zhang HC, et al. Transdemal fentanyl for management of cancer pain in elderly patients in China [J]. Chin-Get J Clin Oncol, 2004, 3 (2) : 85-89.
1Yu SY. Sustained release morphine for cancer pain management. J Clinic Oncology, 1998,3:44-45.于世英.吗啡控释片治疗癌痛的临床研究.临床肿瘤学杂志1998,3:44-45.
2Sun Y. Assesment the quality of life for cancer patients in China. In: SunY, Gu WP, eds Guideline for cancer pain relief by three steps. 2nd ed. Beijing: Beijing Medical University PublishingHouse, 2002. 100-101.孙燕.我国试行的肿瘤病人生活质量评分.见:孙燕
3WHO. Medical nedd for opioid analgesics. In: WHO, ed. Achieving balance in national opioids control policy: guidelines for assessment. Geneva: WHO, 2000, 3-4.
4Joranson DE, Ryan KM, Gilson AM, et al. Trends in medical useand abuse of opioid analgesics. JAMA, 2000, 283:1710-1714.
5Klepstad P, Kaasa S, Jystad A, et al. Immediate- or sustainedrelease morphine for dose finding during start of morphine to cancer patients: a randomized, double-blind trial. Pain, 2003, 101:193-98.
6Warfield CA. Controlled-release morphine tablets in patients with chronic cancer pain. A narrative review of controlled clinical trials. Cancer, 1998, 82:2299-2306.
7Chemy NI. The management of cancer pain. CA Cancer J Clin, 2000, 50: 70-116.
8Tassain V, Attal N, Fletcher D, et al. Long term effects of oral sustained release morphine on neuropsychological performance in patients with chronic non-cancer pain. Pain, 2003, 104:389-400.
9Yu SY, Wang XS, Chen Y, et al. Special aspects of cancer pain management in a Chinese general hospital. Eur J Pain, 2001,5:15-20.
10Wang XS, Li TD, Yu SY, et al. China: Status of pain and palliativecare. J Pain and Sympt Manage, 2002, 24: 177-179.
2Dhingra L, Lam K, Homel P, et al. Pain in underserved community-dwelling Chinese American cancer patients: demographic and medical correlates[J].Oncologist, 2011, 16(4):523.
